538 related articles for article (PubMed ID: 16368566)
1. Wnt/Frizzled signaling in hepatocellular carcinoma.
Lee HC; Kim M; Wands JR
Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.
Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
[TBL] [Abstract][Full Text] [Related]
4. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
[TBL] [Abstract][Full Text] [Related]
5. Wnt/FZD signaling and colorectal cancer morphogenesis.
Hlubek F; Spaderna S; Schmalhofer O; Jung A; Kirchner T; Brabletz T
Front Biosci; 2007 Jan; 12():458-70. PubMed ID: 17127310
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma.
Chan KK; Lo RC
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361730
[TBL] [Abstract][Full Text] [Related]
7. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
8. Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling.
Janda CY; Dang LT; You C; Chang J; de Lau W; Zhong ZA; Yan KS; Marecic O; Siepe D; Li X; Moody JD; Williams BO; Clevers H; Piehler J; Baker D; Kuo CJ; Garcia KC
Nature; 2017 May; 545(7653):234-237. PubMed ID: 28467818
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
10. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
12. Frizzled7 as an emerging target for cancer therapy.
King TD; Zhang W; Suto MJ; Li Y
Cell Signal; 2012 Apr; 24(4):846-51. PubMed ID: 22182510
[TBL] [Abstract][Full Text] [Related]
13. Frizzled Receptors in Tumors, Focusing on Signaling, Roles, Modulation Mechanisms, and Targeted Therapies.
Sun Y; Wang W; Zhao C
Oncol Res; 2021 Mar; 28(6):661-674. PubMed ID: 32998794
[TBL] [Abstract][Full Text] [Related]
14. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level.
Zeng H; Lu B; Zamponi R; Yang Z; Wetzel K; Loureiro J; Mohammadi S; Beibel M; Bergling S; Reece-Hoyes J; Russ C; Roma G; Tchorz JS; Capodieci P; Cong F
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10362-E10369. PubMed ID: 30297426
[TBL] [Abstract][Full Text] [Related]
17. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
[TBL] [Abstract][Full Text] [Related]
18. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
19. Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma.
Nambotin SB; Wands JR; Kim M
Anticancer Agents Med Chem; 2011 Jul; 11(6):549-59. PubMed ID: 21554202
[TBL] [Abstract][Full Text] [Related]
20. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
